PredxBio launches TumorMapr-Basic™ software to process and quantitate multiplexed and hyperplexed image datasets based on either fluorescence or mass spec for rapid and basic measurements. This complements the existing TumorMapr-Advanced™ spatial analytics and explainable AI (xAI) software for developing prognostic/diagnostic tests, drug target identification, clinical trial stratification and personalized therapeutic strategies using computational and systems pathology.
Read more here: Press Release